Les différentes publications des membres du service sont reprises ici dans un ordre chronologique.
Vous pouvez en consulter les résumés sur le MEDLINE à l'adresse http://www.ncbi.nlm.nih.gov/PubMed/. Vous y trouverez toutes les publications médicales référencées.


Publications
1. Symann M, Rodhain J, Huybrechts M, Chatelain C, Humblet Y, Canon JL, Sokal G.
In vivo studies of a murine myeloblastic leukemia. Nouv Rev Franc Hematol 22:63-68, 1980.
2. Symann M, Huybrechts M, Chatelain C, Canon JL, Sokal G.
Regulation of granulocyte and macrophage formation studied in vivo with the diffusion chamber technique. Nouv Rev Franc Hematol 22 : (supplement) 17-24, 1980.
3. Symann M, Anckaert MA, Huybrechts M, Ninane J, Canon JL, Sokal G.
In vivo stimulation and inhibition of granulopoiesis. The effect of an inflammatory reaction on murine diffusion chamber granulopoiesis. Brit J Haematol 51 : 89-98, 1982.
4. Ninane J, Canon JL, Cornu G, Sokal G, Symann M.
Effect of lithium on diffusion chamber granulopoiesis. Int J. Cell Clon 2 : 216-236, 1984.
5. Symann M, Ninane J, Hamood M, Chatelain C, Canon JL, Sokal G.
In vivo stimulation and inhibition of granulopoiesis at the stem cell level. Hematopoietic stem cell physiology. Edt. Eugene P. Cronkite, Alan R. Liss, N.Y. 184:203-212, 1985.
6. Symann M, Humblet Y, Canon JL, Lebacq-Verheyden AM.
Detection of bone marrow metastases in small cell lung cancer by tumor stem cell assay and by monoclonal antibodies.
Dicke KA, Spitzer G, Yagannath S. Eds. : Autologous bone marrow transplantation. Proceeding of the Third International Symposium. Houtson, Texas: University of Texas M.D. Anderson Hospital and Tumor Inst. pg. 509-513, 1986.
7. Humblet Y, Canon JL, Sekhavat M, Feyens AM, Manouvriez P, Lebacq-Verheyden AM, Bazin H, prignot J, Symann M.
Detection of small cell lung cancer bone marrow metastases by immunofluorescence. Pathol. Biol. 36 (1) :25-28, 1988.
8. Canon JL, Humblet Y, Lebacq-Verheyden AM, Prignot J, Symann M.
Immunodetection of small cell lung cancer metastasis in bone marrow using three different monoclonal antibodies. Eur J Cancer Clin Oncol. 24:147-150, 1988.
9. Humblet Y, Feyens AM, Sekhavat M, Agaliotis D, Canon JL, Symann M.
Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts. Cancer Res 49:5058-5061, 1989.
10. Symann M, Humblet Y, Bosly A, Canon JL, Doyen C, Longueville J.
Intensification thérapeutique avec autogreffe de moelle osseuse chez l'adulte. Path. Biol. 37 (9) :969-972, 1989.
11. Canon JL, Humblet Y, Symann M.
Resistance to cisplatin : how to deal with the problem ? Eur. J. Cancer & Clin. Oncol. 26 (1) :1-3, 1990.
12.

Weynants P, Humblet Y, Canon JL, Symann M.
Biology of small lung cancer: a overview. Eur. Resp. J. 3:699-714, 1990.

13.

Canon JL, Longueville J, Humblet Y, Symann M.
Critères de pronostic des cancers du sein sans envahissement des ganglions axillaires. Louvain Méd. 109:667-674, 1990.

14.

Szikora JP, Van Pel A, Brichard V, André M, Van Baren N, De Plaen E, Boon Th.
Structure of the gene of tum- transplantation antigen P35B : presence of a point mutation in the antigenic allele. EMBO J 1990, 9(4), 1041-50.

15.

André M, Canon JL, Levecque P, Dermine P, Mortier C, Leveau F.
Eosinophilia-myalgie syndrome associated with alpha-tryptophan : a case with pulmonary manifestation and review of the litterature. Acta Clinica Belgica 46 (3) :178-182, 1991.
16.

Delannoy A, D'hondt L, Pirson F.
Agranulocytose et crème à la phénazone à propos de 4 cas. Louvain Med 1992; 111: 455-459.

17.

D'Hondt V, Weynants P, Humblet Y, Guillaume T, Canon JL, Beauduin M, Duprez P, Longueville J, Müll R, Chatelain C, Symann M.
Dose-dependent II-3 stimulation of thrombopoiesis and neutropoiesis in patients with small cell lung carcinoma before and following chemotherapy: a placebo controlled randomized phase 1b study. J Clin Oncol 11 (11) :2063-2071, 1993.
18.

D'hondt L, De Prijck B, Fonck C, Donckier J, Buysschaert M.
Maladie de Hantaan.Louvain Med 1993; 112: 215-216.
19.

D'hondt L, Delannoy A, Docquier C.
Hypothyroidism and arthritis during interferon therapy. Clin Rheumatol 1993; 12: 415-417.

20.

Hulstaert R, Van Belle S, Bleiberg H, Canon JL, Dewitte M, Buyse M, De Keyser P.
Optimal combinat ion therapy with tropisetron in 445 patients with subtotal control of chemotherapy-induced nausea and emesis. J Clin Oncol, 12, 11 : 2439-2446, 1994.
21.

André M, Michel F, Thys F, Humblet Y.
La résistance à la chimiothérapie : progrès récents. Acta Clin Belg 1994, 49(5), 214-9.
22.

D'hondt L, Doyen C, Chatelain C, Dumont M, Bosly A.
Neutrophilic eccrine hidradenitis. Acta Clin Belg 1994; 49: 114.

23.

Van Belle S, Cocquyt V, Bleiberg H, Canon JL, Buyse M, Hustaert F, Dewitte M, De Keyser P, Westelinck K for the Belgian Novaban Group.
Optimal combination therapy with NovabanR (Tropisetron) in patients with incomplete control of Chemotherapy -induced Nausea and Vomiting Anti-Cancer Drugs 6, Suppl1 : 22-30, 1995.

24.

Marchand M, Weynants P, Rankin E, Arienti F, Belli F, Parmiani G, Cascinelli N, Bourlond A, Vanwijck R, Humblet Y, Canon JL, Laurent C, Naeyaert JM, Plagne R, Deraemaeker R, Knuth A, Jâger E, Brasseur F, Herman J, Coulie PJ, Boon T.
Tumor regression responses in melanoma patients treated with a peptide encoded by gene Mage 3. 1nt. J. Cancer: 63, 883-885, 1995.

25.

D'hondt L.
Un effet favorable de la greffe de moelle osseuse: la réaction du greffon contre la leucémie. Louvain Med 1995; 114: 109-114.
26.

D'hondt L, Donckier J, Michel L, Lorge F, Delos M, Mertz Jb, Buysschaert M.
Association rare de deux causes d'hypertension artérielle secondaire. Louvain Med 1995; 114: 115-121.
27.

D'hondt L, Bosly A.
Place de la chimiothérapie à haute dose et de l'autogreffe dans le traitement des lymphomes folliculaires. Louvain Med 1995; 114: 381-388.
28.

D'hondt L, Guillaume Th, Humblet Y, Moriau M, Lachapelle Jm, Symann M.
Digital necrosis associated with chronic myeloid leukemia: a rare paraneoplastic phenomenon. Acta Clin Belg 1995; 50: 297-300.

29.

Cucuianu A, D'hondt L, Collignon J, Verhulst D, De Prijck B, Chatelain C, Doyen C, Bosly A.
High-dose cytotoxic therapy with autologous bone marrow or peripheral blood progenitor cell transplantation in malignant lymphoma. Romanian Journal Internal Medecine 1995; 33: 211-225.
30. D'hondt L, Chatelain C, Doyen C, Osselaer Jc, Ferrant A, Bosly A.
Transient complete remission of acute lymphoblastic leukemia in relapse after allogeneic bone marrow transplantation induced by donor leukocyte transfusions. Hematol Cell Ther 1996; 38: 353-354
31.

D'hondt L, Filleul B, Guillaume Th, Humblet Y, Longueville J, Willocx R, Symann M.
Severe anal condylomata acuminata following high-dose chemotherapy and autologous hematopoietic stem cell transplantation: a case report. Acta Gastroenter Belg 1996; 59: 254-255.
32.

André M, Brice P, Cazals D, Hennequin C, Fermé C, Kernéis Y, Rousselot P, Zini JM, Lepage, Gisselbrecht C.
Result of three courses of adriamycin, bleomycin, vindesine and dacarbazine with subtotal nodal irradiation in 189 patients with nodal hodgkin's disease (stage I, II and IIIA). Hematol Cell Ther 1997, 39, 59-65.
33.

D'Hondt L, André M, Guillaume T, Feyens AM, Humblet Y, Doyen C, Bosly A, Dromelet A, Chatelain B, Symann M.
Quantification of CD34+ cells mobilized into the peripheral blood predicts the yield of the leukapheresis product and can replace progenitor assays. Cytokines, Cellular & Molecular Therapy 1997, 3, 21-26.
34.

Brice P, Bouabdallah R, Moreau P, Divine M, André M, Aoudjane M, Fleury J, Anglaret B, Baruchel A, Sensebe L, Colombat P.
Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Bone Marrow Transplant 1997, 20,21-26.
35.

D'Hondt L, André M, Canon JL, Guillaume T, Doyen C, Feyens AM, Chatelain B, Dromelet A, Humblet Y, Longueville J, Symann M.
Efficiency of high-dose FEC chemotherapy for the mobilization of hematopoietic stem cells into peripheral blood. Bull Cancer 1997 Jul;84(7):729-733.
36.

D'hondt L, Guillaume Th, Humblet Y, Symann M.
Digital necrosis associated with chronic myeloid leukemia: a rare paraneoplastic phenomenon.... and not a toxicity of interferon. Acta Clin Belg 1997; 52: 49.

37.

D'Hondt L, Andre M, Guillaume T, Emmons Van Dueren R, Feyens AM, Canon JL, Chatelain B, Humblet Y, Longueville J, Symann M.
The Administration of filgrastim (10g/kg) alone results in successful peripheral blood progenitor all collections when previous mobilization with chemotherapy and hematopoïetic growth factor failed. Leukemia and Lymphoma, 1998. Vol 00 : pl-5.

38.

Sibille-Hoang C, Froment O, Joos de ter Beerst A, Lepiece V, Huberlant G, Blauwaert G, Vindevoghel A, Canon JL, Gillerot Y.
BRCA1 and BRCA2 mutations in Belgian families with a history of breast and/or ovarian cancer. Eur J Cancer Prev 1998;7 Suppl 1:S3-5.

39.

M. André, M. Henry-Amar, D. Blaise, P. Colombat, J.Fleury, N. Milpied, J.-Y. Cahn, J.-L. Pico, Y. Bastion, M. Kuentz, G. Nedellec, M. Attal, C. Ferme, C. Gisselbrecht.
Treatment-Related Deaths and Second Cancer Risk After Autologous Stem-Cell Transplantation for Hodgkin's Disease. Blood 1998 92 (6):1933-40.

40.

van de Velde H, Bosquee L, Weynants P, Canon JL, Rosier JF, Humblet Y.
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clinique de l'Universite Catholique de Louvain, Brussels and Liege, Belgium. Ann Oncol 1999;10:1051-1057.
41.

M. André, M. Henry-Amar, JL. Pico, P. Brice, D. Blaise, M. Kuentz, B. Coiffier, P. Colombat, JY. Cahn, M. Attal, J. Fleury, N. Milpied, G. Nedellec, P. Biron, H. Tilly, JP. Jouet, C. Gisselbrecht.
 Comparison of high-dose therapy and autologous stem transplantation with conventional therapy for Hodgkin's disease induction failure : a case-control study. J Clin Oncol 1999, 17:222-229.
42.

N. Van Baren, F. Brasseur, D. Godelaine, G. Hames, E. Ferrant, F. Lehman, M. André, C. Ravoet, C. Doyen, GC. Spagnoli, M. Bakkus, K. Thielemans, T. Boon.
Genes encoding tumor-specific antigens are expressed in human myeloma cells. Blood 1999, 94 :1156-64.
43.

L. D'Hondt L, RB. Emmons, M. André, T. Guillaume, AM. Feyens, JL. Canon, Y. Humblet, J. Longueville, M. Symann.
The administration of 10µg/kg granulocyte colony-stimulating factor (G-CSF) alone results in a successful peripheral blood stem cell collection when previous mobilisation with chemotherapy and hematopoietic growth factor failed. Leukemia and Lymphoma 1999, 34 :105-109.
44.

L. D'Hondt, J. Wuu, M. André, C. van Lerberghe, T. Guillaume, AM. Feyens, Y. Humblet, A. dromelet, B. Chatelain, J. Longueville, FM. Stewart, V. D'Hondt, M. Symann.
Clearance kinetics of CD34+ cells from peripheral blood : an independant predictor of hematologic recovery after high-dose chemotherapy and hematopoietic stem cell transplantation. Bone Marrow Transplant 1999,24 :483-489.
45.

AS. Govaerts, T. Guillaume, M. André, B. Bayat, AM. Feyens, TS. Hawley, Fong AZ, RG. Hawley, M. Symann.
Retroviral-mediated transfer of genes encoding interleukin-2 and interleukin-12 inti fibriblast increase host antitumor responsiveness. Cancer Gene Ther 1999,6 :447-455.

46.

P. Brice, M. Divine, D. Simon, B. Coiffier, V. Leblond, M. Simon, L. Voilat, A. Devidas, F. Morschhauser, P. Rohrlich, M. André, E. Lepage, V. Fermé.
Feasibility of tandem autologous stem-cell transplantation in induction failure or very unfavorable relapse from Hodgkin's disease. Ann. Oncol. 1999,10 :1485-1488.

47.

Focan C, Bury J, Beauduin M, Herman ML, Vindevoghel A, Lecomte M, Brohee D, Canon JL, Focan-Henrard D.
Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer. Anticancer Res 2000;20:4665-4672.

48.

Richel DJ, Johnsen HE, Canon JL, Guillaume T, Schaafsma MR, Schenkeveld C, Hansen SW, McNiece I, Gringeri AJ, Briddell R, Ewen C, Davies R, Freeman J, Miltenyi S, Symann M.
Highly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients. Bone Marrow Transplant 2000;25:243-249
49.

P. Wijermans, M. Lübbert, G. Verhoef, A. Bosly, C. Ravoet, M. André, A. Ferrant.
Low-Dose 5-Aza-2'-Deoxycytidine, a DNA Hypomethylating Agent, for the Treatment of High-Risk Myelodysplastic Syndrome: A Multicenter Phase II Study in Elderly Patients. J Clin Oncol. 2000,1: 956-62.
50.

E. Van Den Neste, I. Louviaux, JL. Michaux A. Delannoy, L. Michaux, A. Sonet, A. Bosly, C. Doyen, P. Mineur, M. André, N. Straetmans, E. Coche, C. Venet, T. Duprez, A. Ferrant.
Phase I/II study of 2-chloro-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma. Leukemia. 2000, 14 :1136-1142.
51.

C. Jacquy, A. Sorée, F. Lambert, A. Bosly, A. Ferrant, M. André, J. Parma, A. Kentos, P. Martiat.
A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin's lymphoma : one half of patients significantly mobilize malignant cells. Brit. J. Hematol. 2000, 110 :10-18.
52.

Cazals-Hatem D, André M, Mounier N, Divine M, Berger F, Kerneis Y, Brière J, Quesnel B, Gaulard Ph, Diebold J.
Pathological and clinical characteristics of 76 Hodgkin's disease (HD) patients misincluded in a lymphoma protocol (LNH87). Am J Surg Pathol. 2001;25:297-306.
 
  Chapître de livre
  Gisselbrecht C, André M. Autogreffe de moelle osseuse dans la maladie de Hodgkin. Dans Solal-céligny Ph, Brousse N, Fermé Ch, Gisselbrecht Ch, Reyes F, Coiffier B (Eds). Lymphomes : lymphomes non-Hodgkiniens - maladie de Hodgkin (3è édition), Frison-Roche, France, 1997,498-504 .